Showing results (11-20 of 235) with videos related to
Sort By:
Pageof 24
American Heart Journal|December 13, 2005
Obesity as a prognostic factor in chronic symptomatic heart failureBiykem Bozkurt, Anita DeswalAnnals of Internal Medicine|April 3, 2023
In thrombotic antiphospholipid syndrome, DOACs vs. VKAs increase arterial thrombotic events but not major bleedingEfstratios Koutroumpakis, Anita DeswalJournal of Cardiac Failure|October 25, 2002
The fragility of cardiovascular clinical trial resultsLemuel A Moyé, Anita DeswalAnnals of Internal Medicine|November 16, 2020
In heart failure, adding empagliflozin to medical therapy reduced a composite of CV death or HF hospitalizationNicolas L Palaskas, Anita DeswalAnnals of Internal Medicine|March 31, 2025
In adults with HF with preserved ejection fraction and obesity, tirzepatide reduced a composite of CV death or worsening HF at 2 yLeslie A Ynalvez, Anita Deswal, Annals of Internal Medicine|December 4, 2023
In patients with HFpEF and obesity, semaglutide increased weight loss and reduced symptoms and physical limitations at 52 wkHyeon-Ju Ali, Anita DeswalAmerican Journal of Therapeutics|March 12, 2003
Perils of the random experimentLemuel A Moyé, Anita DeswalCurrent Opinion in Cardiology|January 4, 2021
COVID-19 myocarditis and long-term heart failure sequelaeJing Liu, Anita Deswal, Umair KhalidCurrent Atherosclerosis Reports|March 15, 2016
Obesity and Cardiovascular Disease: a Risk Factor or a Risk Marker?Taher Mandviwala, Umair Khalid, Anita DeswalCurrent Opinion in Cardiology|April 3, 2008
Advances in the treatment of heart failure with a preserved ejection fractionAparajita Das, Selwin Abraham, Anita DeswalPageof 24